The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed ...

The chip is expected to be available in Q4 2025 for first customers integrating post-quantum security into their designs ...

Which city is the world’s largest producer of blood bags? Which city manufactures the world’s most affordable artificial ...

Therapists working in today’s ever-evolving healthcare landscape know that keeping up with coding changes isn’t just an ...

Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year. Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million. Full-year 2025 ...

REVERSE-HF clinical trial, a randomized post-market trial evaluating ultrafiltration vs. IV loop diuretic therapy for fluid management in hospitalized heart failure patients. This decision reflects ...

In an era where technological advancements are redefining the healthcare sector, Zimmer Biomet, a leading medical device company, is embracing change through strategic acquisitions. The recent ...

With the newly published Life Sciences Sector Plan coming soon after the 10 Year Health Plan for England, Sally Gainsbury ...

Healthcare and tech company bosses, including the co-founders of the ASX’s newest $30 billion company Pro Medicus, dominate ...

D. Y. Patil Dean shares how future doctors are trained in AI, research, soft skills, and diverse careers, with strong focus on well-being and mentorship.

Abbott beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its medical devices, including continuous glucose monitors.

Abbott beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its medical devices including continuous glucose monitors.